According to Aurinia Pharmaceuticals
's latest financial reports the company's current revenue (TTM ) is NZ$0.38 Billion. In 2023 the company made a revenue of NZ$0.27 Billion an increase over the revenue in the year 2022 that were of NZ$0.21 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 (TTM) | NZ$0.35 B | 28.35% |
2023 | NZ$0.27 B | 31.47% |
2022 | NZ$0.21 B | 216.18% |
2021 | NZ$66.76 M | -3.88% |
2020 | NZ$69.45 M | 14610.57% |
2019 | NZ$0.47 M | -31.59% |
2018 | NZ$0.69 M | 17% |
2017 | NZ$0.58 M | 136.22% |
2016 | NZ$0.24 M | -27.26% |
2015 | NZ$0.34 M | -3.23% |
2014 | NZ$0.35 M | -69.3% |
2013 | NZ$1.15 M | -84.35% |
2012 | NZ$7.38 M | 509.62% |
2011 | NZ$1.21 M | -72.57% |
2010 | NZ$4.41 M | 16.68% |
2009 | NZ$3.78 M | -43.88% |
2008 | NZ$6.74 M | 134.23% |
2007 | NZ$2.87 M | -41.43% |
2006 | NZ$4.91 M | -1068.94% |
2005 | -NZ$0.51 Million | -129.19% |
2004 | NZ$1.73 M | -85.26% |
2003 | NZ$11.79 M | -49.18% |
2002 | NZ$23.21 M | |
2000 | NZ$2.01 M | -22.65% |
1999 | NZ$2.59 M |